- Zacks
Is It Wise to Hold Bio-Rad (BIO) Stock in Your Portfolio Now?
Bio-Rad's (BIO) robust digital PCR business and Clinical Diagnostics segment raise optimism. However, macro issues raise concerns.
- Insider Monkey
Is Bio-Rad Laboratories (BIO) a Lucrative Investment?
Ariel Investments, an investment management company, released its “Ariel Appreciation Fund” first-quarter 2024 investor letter. A copy of the letter can be downloaded here. The Ariel Appreciation fund increased +4.06% in the quarter, trailing the +8.23% and +8.60% returns of the Russell Midcap Value and Russell Midcap indices. Except for real estate, all sectors in the […]
- Zacks
Phibro (PAHC) Down 3.3% Since Last Earnings Report: Can It Rebound?
Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
